Developing Countries Vaccine Manufacturers Network (DCVMN) 20th Annual General Meeting
21 to 23 October 2019 - Rio de Janeiro, Brazil
10th APS International PharmSci Conference
11 to 13 September 2019 - Greenwich, UK
Developing Countries Vaccine Manufacturers Network (DCVMN) Workshop on supply chain
25 June 2019 - Geneva, Switzerland
Developing Countries Vaccine Manufacturers Network (DCVMN) Workshop on vaccine release test methods aimed at reducing animal use
10 to 13 June 2019 - Hyderabad, India
Global Science Policy Forum: Developing a Vaccine Revolution
23 May 2019 - London, UK
FVMR Hub Director Professor Robin Shattock and Hub member Professor Jason Hallett presented at the Imperial Global Science Policy Forum on 23 May 2019 in London, UK
Annual Future Vaccine Manufacturing Research Hub Meeting
15 to 16 April 2019 - London, UK
The FVMR Hub held its annual meeting in London, to update on progress and plan next steps, with all partners.
World Economic Forum
22 to 25 January 2019 - Davos, Switzerland
Professor Robin Shattock and Professor Jason Hallett from the FVMR Hub presented at the World Economic Forum, highlighting the need to improve vaccine manufacturing capabilities for manufacturers in developing countries.
Developing Countries Vaccine Manufacturers Network (DCVMN) Annual General Meeting
29 to 31 October 2018 - Kunming, China
The DCVMN was established in the year 2000, sharing the vision of protecting all people against known and emerging infectious diseases, with the mission of increasing the quality and availability of vaccines affordable to all.
Future vaccines research and development: advancing the manufacturing and deployment of cost-effective vaccines in a changing landscape
21 May 2018 at Imperial College London
KTN held this event, in partnership with Imperial College, on 21st May in London. The meeting brought together the vaccine development and manufacturing community in human health in the UK, to learn about the latest innovative technologies, hear about current UK capabilities and Department of Health and Social Care investments to date, the work of the UK Vaccine Network, Future Vaccines Manufacturing Research hub(s) and also potentially future opportunities for funding through mechanisms such as the Industrial Strategy Challenge Fund.
Approximately 50 delegates attended on the day from the wider sector. Thanks to the support of our hosts, and supporters, KTN was able to deliver this meeting as a free event for the community. The event aligned with the KTN’s activities in medicines bioprocessing and manufacturing, as well as the Medicines Manufacturing Industry Partnership (MMIP).